X

Health Care

IQVIA Holdings Inc. (IQV) Q1 2021 Earnings Call Transcript

IQVIA Holdings Inc.  (NYSE: IQV) Q1 2021 earnings call dated Apr. 22, 2021. Corporate Participants: Andrew Markwick -- Senior Vice…

Biogen Inc. (BIIB) Q1 2021 Earnings Call Transcript

Biogen Inc. (NASDAQ: BIIB) Q1 2021 earnings call dated Apr. 22, 2021 Corporate Participants: Mike Hencke -- Director of Investor Relations Michel…

Quest Diagnostics Inc (DGX) Q1 2021 Earnings Call Transcript

Quest Diagnostics Inc (NYSE: DGX) Q1 2021 earnings call ended Apr. 22, 2021 Corporate Participants: Shawn Bevec -- Vice President of Investor…

Infographic: How Biogen (BIIB) performed in Q1 2021

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today. Total revenues decreased 24% year-over-year to $2.6 billion. On…

Intuitive Surgical (ISRG): Here’s the main theme behind Q1 results and for the year ahead

Shares of Intuitive Surgical Inc. (NASDAQ: ISRG) were up over 10% on Wednesday. The stock has gained 74% over the…

Johnson & Johnson (JNJ) Q1 2021 Earnings Call

Johnson & Johnson  (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Joseph J.…

Anthem, Inc. (ANTM) Q1 2021 Earnings Call Transcript

Anthem, Inc.  (NYSE: ANTM) Q1 2021 earnings call dated Apr. 21, 2021 Corporate Participants: Stephen Tanal -- Vice President of Investor Relations…

Intuitive Surgical Inc. (ISRG) Q1 2021 Earnings Call Transcript

Intuitive Surgical Inc. (NASDAQ: ISRG) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Philip Kim -- Head of Investor Relations…

Edwards Lifesciences Corp. (EW) Q1 2021 Earnings Call Transcript

Edwards Lifesciences Corp. (NYSE: EW) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Mark Wilterding -- Vice President, Investor Relations…

Key highlights from Intuitive Surgical (ISRG) Q1 2021 earnings results

Intuitive Surgical, Inc. (NASDAQ: ISRG) reported first quarter 2021 earnings results today. Revenues increased 18% year-over-year to $1.29 billion, driven…

Johnson & Johnson (JNJ) Q1 2021 Earnings Call Transcript

Johnson & Johnson  (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice -- Vice President of Investor…

Abbott Laboratories (ABT) Q1 2021 Earnings Call Transcript

Abbott Laboratories (NYSE: ABT) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Scott Michael Leinenweber -- Vice President of Investor…

Abbott Laboratories (ABT) Earnings: 1Q21 Key Numbers

Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today. Sales increased 35.3% year-over-year to $10.5 billion. On an…

Johnson & Johnson (JNJ) reports Q1 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

Mitesco aims to build a consumer-focused chain of clinics

Mitesco Inc (OTCQB: MITI) CEO Lawrence Diamond, a man with over 25 years of experience in the healthcare space, strongly…

UnitedHealth Group Inc. (UNH) Q1 2021 Earnings Call Transcript

UnitedHealth Group Inc. (NYSE: UNH) Q1 2021 earnings call dated Apr. 15, 2021 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk…

The worst seems to be over for Boston Scientific. Is the stock a buy?

The pandemic has had a mixed impact on the healthcare sector since its outbreak more than a year ago, putting…

Two areas that provide Pfizer (PFE) with ample opportunity for future growth

Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past one year. Pfizer is at the forefront…

Organigram Holdings Inc.(OGI) Q2 2021 Earnings Call Transcript

Organigram Holdings Inc. (NASDAQ: OGI) Q2 2021 earnings call dated Apr. 13, 2021. Corporate Participants: Amy Schwalm -- Vice President,…

Aphria Inc. (APHA) Q3 2021 Earnings Call

Aphria Inc.  (NASDAQ: APHA) Q3 2021 earnings call dated Apr. 12, 2021 Corporate Participants: Carl Merton — Chief Financial Officer Irwin D. Simon — Chief…

It’s worth keeping an eye on Vertex Pharma (VRTX) stock. Here’s why

After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical…